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Introduction
Dyslipidemia includes a number of different patholog-
ical conditions whose common element is a disorder of
lipid metabolism, and their subsequent alteration of the
concentrations of lipids and lipoproteins in the blood.
This is a common metabolic disorder during pregnancy
that persists in the postpartum period (until 40 days fol-
lowing childbirth) and even later. 
Triglycerides constitute 90% of our body fat and their
normal value is 150 mg/dl. Cholesterol acts on the com-
position of molecules of vitamin D, hormones, and bile
acids; its normal value is 200 mg/dl. Whatever the type,
a lipidic disorder increases the risk of atherosclerosis and
heart disease [1].
During the first two quarters of pregnancy, there is an
increased lipid storage with a lipolysis similar to non-
pregnant women and in later stages, as fetal nutritional
demands have significantly increased, the maternal
reserves decrease. The low-density lipoprotein (LDL)
reaches its maximum at about 36 weeks due to liver
effects of estradiol and progesterone. The high-density
lipoprotein (HDL) reaches its maximum at about 25
weeks, decreases at about 32 weeks, and holds steady
during the rest of pregnancy [2]. 
A significant percentage of pregnant women go on to
develop hypertension associated with preeclampsia, dys-
lipidemia, gestational diabetes, and maternal obesity. The
long-term consequences of these conditions have not been
adequately investigated in controlled clinical studies [3].
Unfortunately, there are limited treatment options for the
possible complications to the binomial mother-child and
most studies on the subject are still at an early stage [4]. 
In Mexico, the prevalence of metabolic diseases is
rising and our concern about the high rates of maternal
and infant mortality has led the authors to study the
female population in the process of puerperium with per-
sistent dyslipidemia. In the Obstetric Intensive Care Unit
(OICU) of the Materno Perinatal Hospital “Monica
Pretelini” (HMPMP), State Health System of the State of
Mexico (ISEM), levels of cholesterol and triglycerides
were monitored in all patients. 
Preeclampsia, defined as the increase in blood pressure
accompanied by edema, proteinuria or both, that occurs
after the 20th week of gestation, is considered a diffuse
endothelial disorder, which complicates 6%-10% of preg-
nancies [5]. This entity is characterized by increased vas-
cular resistance, vasoconstriction, metabolic changes in
nitric oxide (NO), lipids and prostaglandins, in addition
to clotting abnormalities [6]. 
Eclampsia is defined as the development of seizures
due to hypertensive encephalopathy in a preeclamptic
patient, not attributed to other causes. Its incidence is
close to one per 2,000 births. Seizures, which are the sign
of eclampsia, are preceded by manifestations of
preeclampsia, although 20% of seizures can occur up to
six days after delivery [7]. 
Surprisingly, despite its high prevalence, information
related to dyslipidemia in puerperium is scarce. Thus,
further examination of the implications of dyslipidemia
in puerperium is mandatory.
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The authors’ principal aim was to compare serum
levels of triglycerides and cholesterol and the dyslipi-
demic factor (DLF): (triglycerides (mg/dl)/150) X (cho-
lesterol (mg/dl)/200), among puerperal women compli-
cated or not with preeclampsia.
Materials and Methods 
This was a cohort, observational, prospective, comparative
and longitudinal study developed in the HMPMP, Toluca,
Mexico, during the period from August 1st, 2009 to March 30th,
2010. 
Participants
Women in postpartum were between 16 and 46-years-old.
Those with premature membrane rupture, with a previous
known chronic-metabolic disease (diabetes, pregestational dys-
lipidemia, and hypertension), or with incomplete medical
records were excluded from this study. 
Three groups were conformed: group A included puerperal
women without complications (physiological puerperium),
group B puerperal women complicated with preeclampsia, and
group C puerperal women complicated with preeclampsia
requiring attention at the OICU (Figure 1).
Preeclampsia was defined as gestational hypertension (sys-
tolic blood pressure more than 140 mm Hg and diastolic blood
pressure more than 90 mm Hg) and proteinuria (at least 300 mg
of urine protein in 24 h). Women requiring attention at the
OICU were those with severe criteria: organ damage [8] or
severe hypertension requiring i.v. drugs (sodium nitroprusside
or nitroglycerin). 
Data and measures
The data accessed in the clinical records of each patient was
entered in an Excel spreadsheet previously designed by the
researchers.
Blood pressure was measured with electronic monitor in the
Triage room and during hospitalization.
The SPSS version 16 was used for statistical analysis. Con-
tinuous variables were expressed in means ± standard deviation
(SD). As there was no a normal distribution, the authors com-
pared the groups using the Kruskal Wallis test and the Mann-
Whitney U test for differences between two groups. A p ≤ value
≤ 0.05 was considered statistically significant. 
Laboratory
After delivery and for three days, with a fasting period of
eight hours, the authors measured albumin (mg/dl), calcium
(mg/dl), cholesterol (mg/dl), creatinine (mg/dl), glucose
(mg/dl), magnesium (mg/dl), triglycerides (mg/dl), uric acid
(mg/dl), and hemoglobin (g/dl). Very low-density lipoproteins
(VLDL) were calculated as triglycerides (mg/dl)/5. 
This study was approved by the Ethical and Research Com-
mittee of the HMPMP (date: July 2, 2009).
Results
For the eight month period, the authors compiled com-
plete laboratory results of 14 puerperal women without
complications (median age 27.2 ± 10.1 years), 11 puer-
peral women complicated with preeclampsia (median age
22.9 ± 6.5 years), and 22 puerperal women complicated
with preeclampsia requiring attention at the OICU
(median age 27.8 ± 7 years). Table 1 shows the labora-
tory characteristics of the three groups. There was a sta-
tistical significant difference in albumin and cholesterol
levels between puerperal women without complications
and puerperal women complicated with preeclampsia, as
well as in albumin, creatinine, and uric acid between
puerperal women complicated with preeclampsia and
puerperal women complicated with preeclampsia who
attended the OICU.
When analyzed more precisely, 13 (92.8%) puerperal
women without complications, 100% of puerperal
women complicated with preeclampsia, and puerperal
women complicated with preeclampsia requiring atten-
tion at the OICU had triglycerides higher than 150 mg/dl
at least three days post-delivery. Furthermore, six
(42.8%) puerperal women without complications, one
(9%) puerperal woman complicated with preeclampsia,
and eight (36.3%) puerperal women complicated with
preeclampsia requiring attention at the OICU had levels
in crescendo.
Figure 1. — Flowchart of the groups analyzed.
OICU: Obstetric Intensive Care Unit.
Table 1. — Laboratory results from the three groups analyzed.
Group A Group B Group C 
(n = 14) (n = 11) (n = 22)
Age (years) 27.2 ± 10.1 22.9 ± 6.5 27.8 ± 7 
Albumin (mg/dl)*† 3.1 ± 0.49 2.5 ± 0.6 2.9 ± 0.7
Calcium (mg/dl) 7.8 ± 0.9 7.9 ± 0.7 7.6 ± 0.6
Cholesterol (mg/dl)* 162.4 ± 4 206.6 ± 80.7 181.3 ± 54.4
Creatinine (mg/dl)† 1 ± 0.7 0.6 ± 0.1 1 ± 0.6
DLF* 1 ± 0.6 2.4 ± 2.1 1.5 ± 0.7
Glucose (mg/dl) 97.1 ± 35 105 ± 49.6 108.4 ± 49.2
Magnesium (mg/dl) 2.9 ± 0.9 2.2 ± 1 2.5 ± 0.9
Triglycerides (mg/dl) 227.9 ± 66 304.4 ± 162.7 244.4 ± 60.4
Uric acid (mg/dl)† 5.3 ± 2.4 5.1 ± 1.1 5.7 ± 1.5
VLDL (mg/dl) 46 ± 13.3 60.8 ± 32.5 48.8 ± 12
Hemoglobin (g/dl) 10.1 ± 1.5 11 ± 2.2 10.4 ± 1.8
Group A: puerperal women without complications, Group B: puerperal women
complicated with preeclampsia, Group C: puerperal women complicated with
preeclampsia requiring attention at the OICU; DLF: dyslipidemic factor =
(triglycerides (mg/dl)/150) X (cholesterol (mg/dl)/200); OICU: Obstetric Intensive
Care Unit; VLDL: very low density lipoproteins
*: p ≤ 0.05 between group A and group B.
†: p ≤ 0.05 between group B and group C.
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In relation to cholesterol, two (14.2%) puerperal
women without complications, six (54.5%) puerperal
women complicated with preeclampsia, and 11 (50%)
puerperal women complicated with preeclampsia requir-
ing attention at the OICU had serum values higher than
200 mg/dl at least one day during post-delivery. Further-
more, five (35.7%) puerperal women without complica-
tions, two (18.1%) puerperal women complicated with
preeclampsia, and nine (40.9%) puerperal women com-
plicated with preeclampsia requiring attention at the
OICU had levels in crescendo. The p value was of 0.027
between puerperal women without complications and
puerperal women complicated with preeclampsia.
Only two (14.2%) puerperal women without complica-
tions, six (54.5 %) puerperal women complicated with
preeclampsia, and 11 (50%) puerperal women compli-
cated with preeclampsia requiring attention at the OICU
had both triglycerides and cholesterol levels above
normal limits at least once. DLF showed a statistically
significant difference between puerperal women without
complications and puerperal women complicated with
preeclampsia (p ≤ 0.05).
In relation to glucose, two (14.2%) puerperal women
without complications, one (9%) puerperal woman com-
plicated with preeclampsia, and two (9%) puerperal
women complicated with preeclampsia requiring atten-
tion at the OICU had levels higher than 100 mg/dl.
Besides the results previously commented, the anemic
state of most of the women was brought to the authors’
attention as Toluca City is 2,500 m above sea level and
the minimum value for hemoglobin should be 12.3 g/dl
[9].
Discussion
In a normal pregnancy, serum cholesterol and triglyc-
erides rise 25%-40% and 200%-400%, respectively. A
supraphysiologic rise in plasma triglycerides’ concentra-
tions in late pregnancy may serve as a marker of pre-
lipemia [10]. The metabolic syndrome, defined by
abdominal obesity, elevation of blood pressure, fasting
glucose and triglycerides, and low levels of HDL, may
play an important role in the pathogenesis of unsuccess-
ful pregnancy, by including a pro-inflammatory and pro-
thrombotic state [11]. Inflammation in women with spon-
taneous preterm birth might be related to their metabolic
profile, such as lipids [12]. Unfortunately, lipid profiles
are not routinely measured in all pregnant women, which
might indicate that the true prevalence of dyslipidemia is
under-estimated [13].
Several studies have examined the development of the
metabolic syndrome in pregnant women [14] and there
are several criteria and indexes to evaluate the repercus-
sion of metabolic disturbances during pregnancy, such as
insulin-like growth factors (IGFs), insulin-like growth
factor binding proteins (IGFBPs), leptin, homeostasis
model assessment (HOMA), maternal insulin sensitivity,
etc. [15], but the information related to puerperium is
scarce [16]. Considering the context of other work, the
authors agree that women should be followed up until 42
days postpartum [17]. Moreover, every postpartum visit
should include the evaluation components of the meta-
bolic syndrome and not only glucose intolerance [18]. In
the present study the authors analyzed the post-pregnancy
presence of dyslipidemia in women with physiological or
complicated puerperium. The importance of this issue is
emphasized by the continuous increase in the prevalence
of dyslipidemia [19].
The atherogenic index of plasma (AIP = Log(triglyc-
erides/HDL)), correlates with the size of pro- and anti-
atherogenic lipoprotein particles. Clinical studies have
shown that AIP predicts cardiovascular risk [20].
Although AIP is a useful cardiovascular risk marker and
measure of response to treatment, it is not common to
check HDL in all pregnant and puerperal women.
According to the present authors’ point of view, DLF pro-
posed in this study could be a useful tool to evaluate a
mixed lipemic state with a good cost-benefit approach.
Certainly a study designed to obtain ROC curves for the
factor suggested by the present authors to be considered
in clinical practice is still missing.
Systolic hypertension and hypercholesterolemia are
both considered other variables to determine the Fram-
ingham score, moreover, arterial coronary disease or
equivalents or diabetes are considered as coronary risk
factors. Preeclampsia, as well as the other diseases previ-
ously mentioned, produce endothelial dysfunction, in
fact, preeclamptic women have an incresead risk to
develop this complication in a subsequent pregnancy. The
authors suggest, therefore, that preeclampsia and dyslipi-
demia might be considered as risk factors in developing
a chronic endothelial disease (CED). 
Finally, several limitations to this study need to be
mentioned. Firstly, this was a study with a low number of
patients. Secondly, puerperal women were not systemat-
ically followed up after their delivery to take blood
samples to monitor triglycerides and cholesterol levels. 
Conclusion
HDL is not usually measured in all pregnant and puer-
peral women. According to the authors’ point of view,
DLF could be a useful tool in evaluating a mixed lipemic
state with a good cost-benefit approach.
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